Key result
Chronic use of amiodarone can present as a chronic inflammatory demyelinating polyneuropathy-like presentation, accompanied by pulmonary toxicity.
Why the study?
Long-term administration of amiodarone may lead to diverse neurological complications and systemic involvement, which can be overlooked without high clinical suspicion.
Population
A 46-year-old male patient presenting with paresthesia and progressive four-limb weakness
Design
Case report
Authors
Loading...
Clinicians should consider amiodarone toxicity in CIDP-like neuropathy with pulmonary symptoms; leaves open confirmation in larger cohorts.
Case Report (n=1)
Chronic use of amiodarone can present as a CIDP-like neuropathy and pulmonary toxicity, requiring high clinical suspicion to avoid overlooking the diagnosis.
Okhovat et al. (2020) conducted a case report in Amiodarone-induced neuropathy (n=1). Amiodarone was evaluated. Chronic use of amiodarone can present as a chronic inflammatory demyelinating polyneuropathy-like presentation, accompanied by pulmonary toxicity.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: